List of Tables
Table 1. Incretin-Based Drugs Market Trends
Table 2. Incretin-Based Drugs Market Drivers & Opportunity
Table 3. Incretin-Based Drugs Market Challenges
Table 4. Incretin-Based Drugs Market Restraints
Table 5. Global Incretin-Based Drugs Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Incretin-Based Drugs Revenue Market Share by Company (2019-2024)
Table 7. Global Incretin-Based Drugs Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Incretin-Based Drugs Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Incretin-Based Drugs Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers Incretin-Based Drugs Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Incretin-Based Drugs Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Incretin-Based Drugs
Table 13. Global Incretin-Based Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Incretin-Based Drugs as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Incretin-Based Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Incretin-Based Drugs Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Incretin-Based Drugs Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Incretin-Based Drugs Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Incretin-Based Drugs Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Incretin-Based Drugs Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Incretin-Based Drugs Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Incretin-Based Drugs Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Incretin-Based Drugs Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Incretin-Based Drugs Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Incretin-Based Drugs Price by Type (2019-2024) & (US$/Unit)
Table 27. Global Incretin-Based Drugs Price by Type (2025-2030) & (US$/Unit)
Table 28. Global Incretin-Based Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Incretin-Based Drugs Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Incretin-Based Drugs Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Incretin-Based Drugs Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Incretin-Based Drugs Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Incretin-Based Drugs Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Incretin-Based Drugs Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Incretin-Based Drugs Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Incretin-Based Drugs Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Incretin-Based Drugs Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Incretin-Based Drugs Price by Application (2019-2024) & (US$/Unit)
Table 39. Global Incretin-Based Drugs Price by Application (2025-2030) & (US$/Unit)
Table 40. Global Incretin-Based Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Incretin-Based Drugs Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Incretin-Based Drugs Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Incretin-Based Drugs Sales Value by Region (2019-2024) & (%)
Table 44. Global Incretin-Based Drugs Sales Value by Region (2025-2030) & (%)
Table 45. Global Incretin-Based Drugs Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Incretin-Based Drugs Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Incretin-Based Drugs Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Incretin-Based Drugs Sales Volume by Region (2019-2024) & (%)
Table 49. Global Incretin-Based Drugs Sales Volume by Region (2025-2030) & (%)
Table 50. Global Incretin-Based Drugs Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global Incretin-Based Drugs Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions Incretin-Based Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Incretin-Based Drugs Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Incretin-Based Drugs Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Incretin-Based Drugs Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Incretin-Based Drugs Sales Volume, (2025-2030) & (K Units)
Table 57. GlaxoSmithKline Company Information
Table 58. GlaxoSmithKline Introduction and Business Overview
Table 59. GlaxoSmithKline Incretin-Based Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. GlaxoSmithKline Incretin-Based Drugs Product Offerings
Table 61. GlaxoSmithKline Recent Development
Table 62. Johnson & Johnson Company Information
Table 63. Johnson & Johnson Introduction and Business Overview
Table 64. Johnson & Johnson Incretin-Based Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. Johnson & Johnson Incretin-Based Drugs Product Offerings
Table 66. Johnson & Johnson Recent Development
Table 67. Merck & Co Company Information
Table 68. Merck & Co Introduction and Business Overview
Table 69. Merck & Co Incretin-Based Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. Merck & Co Incretin-Based Drugs Product Offerings
Table 71. Merck & Co Recent Development
Table 72. AstraZeneca Company Information
Table 73. AstraZeneca Introduction and Business Overview
Table 74. AstraZeneca Incretin-Based Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. AstraZeneca Incretin-Based Drugs Product Offerings
Table 76. AstraZeneca Recent Development
Table 77. Novartis Company Information
Table 78. Novartis Introduction and Business Overview
Table 79. Novartis Incretin-Based Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Novartis Incretin-Based Drugs Product Offerings
Table 81. Novartis Recent Development
Table 82. Eli Lilly and Company Company Information
Table 83. Eli Lilly and Company Introduction and Business Overview
Table 84. Eli Lilly and Company Incretin-Based Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Eli Lilly and Company Incretin-Based Drugs Product Offerings
Table 86. Eli Lilly and Company Recent Development
Table 87. Boehringer Ingelheim Company Information
Table 88. Boehringer Ingelheim Introduction and Business Overview
Table 89. Boehringer Ingelheim Incretin-Based Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Boehringer Ingelheim Incretin-Based Drugs Product Offerings
Table 91. Boehringer Ingelheim Recent Development
Table 92. Takeda Pharmaceutical Company Company Information
Table 93. Takeda Pharmaceutical Company Introduction and Business Overview
Table 94. Takeda Pharmaceutical Company Incretin-Based Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Takeda Pharmaceutical Company Incretin-Based Drugs Product Offerings
Table 96. Takeda Pharmaceutical Company Recent Development
Table 97. Sanofi Company Information
Table 98. Sanofi Introduction and Business Overview
Table 99. Sanofi Incretin-Based Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. Sanofi Incretin-Based Drugs Product Offerings
Table 101. Sanofi Recent Development
Table 102. Key Raw Materials Lists
Table 103. Raw Materials Key Suppliers Lists
Table 104. Incretin-Based Drugs Downstream Customers
Table 105. Incretin-Based Drugs Distributors List
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Incretin-Based Drugs Product Picture
Figure 2. Global Incretin-Based Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Incretin-Based Drugs Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Incretin-Based Drugs Sales Volume (2019-2030) & (K Units)
Figure 5. Global Incretin-Based Drugs Sales Price (2019-2030) & (US$/Unit)
Figure 6. Incretin-Based Drugs Report Years Considered
Figure 7. Global Incretin-Based Drugs Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Incretin-Based Drugs Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Incretin-Based Drugs Revenue in 2023
Figure 10. Incretin-Based Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Glucagon-like peptide-1 receptor (GLP-1) agonists Picture
Figure 12. Dipeptidyl Peptidase-4 (DPP-4) inhibitors Picture
Figure 13. Global Incretin-Based Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Incretin-Based Drugs Sales Value Market Share by Type, 2023 & 2030
Figure 15. Global Incretin-Based Drugs Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 16. Global Incretin-Based Drugs Sales Volume Market Share by Type, 2023 & 2030
Figure 17. Global Incretin-Based Drugs Price by Type (2019-2030) & (US$/Unit)
Figure 18. Product Picture of Oral Drugs
Figure 19. Product Picture of Injectable Drugs
Figure 20. Global Incretin-Based Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 21. Global Incretin-Based Drugs Sales Value Market Share by Application, 2023 & 2030
Figure 22. Global Incretin-Based Drugs Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 23. Global Incretin-Based Drugs Sales Volume Market Share by Application, 2023 & 2030
Figure 24. Global Incretin-Based Drugs Price by Application (2019-2030) & (US$/Unit)
Figure 25. North America Incretin-Based Drugs Sales Value (2019-2030) & (US$ Million)
Figure 26. North America Incretin-Based Drugs Sales Value by Country (%), 2023 VS 2030
Figure 27. Europe Incretin-Based Drugs Sales Value (2019-2030) & (US$ Million)
Figure 28. Europe Incretin-Based Drugs Sales Value by Country (%), 2023 VS 2030
Figure 29. Asia Pacific Incretin-Based Drugs Sales Value (2019-2030) & (US$ Million)
Figure 30. Asia Pacific Incretin-Based Drugs Sales Value by Country (%), 2023 VS 2030
Figure 31. South America Incretin-Based Drugs Sales Value (2019-2030) & (US$ Million)
Figure 32. South America Incretin-Based Drugs Sales Value by Country (%), 2023 VS 2030
Figure 33. Middle East & Africa Incretin-Based Drugs Sales Value (2019-2030) & (US$ Million)
Figure 34. Middle East & Africa Incretin-Based Drugs Sales Value by Country (%), 2023 VS 2030
Figure 35. Key Countries/Regions Incretin-Based Drugs Sales Value (%), (2019-2030)
Figure 36. Key Countries/Regions Incretin-Based Drugs Sales Volume (%), (2019-2030)
Figure 37. United States Incretin-Based Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 38. United States Incretin-Based Drugs Sales Value by Type (%), 2023 VS 2030
Figure 39. United States Incretin-Based Drugs Sales Value by Application (%), 2023 VS 2030
Figure 40. Europe Incretin-Based Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 41. Europe Incretin-Based Drugs Sales Value by Type (%), 2023 VS 2030
Figure 42. Europe Incretin-Based Drugs Sales Value by Application (%), 2023 VS 2030
Figure 43. China Incretin-Based Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 44. China Incretin-Based Drugs Sales Value by Type (%), 2023 VS 2030
Figure 45. China Incretin-Based Drugs Sales Value by Application (%), 2023 VS 2030
Figure 46. Japan Incretin-Based Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 47. Japan Incretin-Based Drugs Sales Value by Type (%), 2023 VS 2030
Figure 48. Japan Incretin-Based Drugs Sales Value by Application (%), 2023 VS 2030
Figure 49. South Korea Incretin-Based Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 50. South Korea Incretin-Based Drugs Sales Value by Type (%), 2023 VS 2030
Figure 51. South Korea Incretin-Based Drugs Sales Value by Application (%), 2023 VS 2030
Figure 52. Southeast Asia Incretin-Based Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 53. Southeast Asia Incretin-Based Drugs Sales Value by Type (%), 2023 VS 2030
Figure 54. Southeast Asia Incretin-Based Drugs Sales Value by Application (%), 2023 VS 2030
Figure 55. India Incretin-Based Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 56. India Incretin-Based Drugs Sales Value by Type (%), 2023 VS 2030
Figure 57. India Incretin-Based Drugs Sales Value by Application (%), 2023 VS 2030
Figure 58. Incretin-Based Drugs Industrial Chain
Figure 59. Incretin-Based Drugs Manufacturing Cost Structure
Figure 60. Channels of Distribution (Direct Sales, and Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
